Therapeutic Vaccines
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT06643143
A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2025
Completion: Jun 30, 2027
Loading map...